| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/01/1992 | CA2072105A1 Mutation of hrv2 2a |
| 03/01/1992 | CA2050063A1 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 03/01/1992 | CA2049625A1 Method for isolating enzymes from enzyme-containing suspensions |
| 02/27/1992 | DE4033246C1 Phenol-oxidising enzyme prodn. - by growing wet hot fungi on medium of potato pulp and potato fruit juice |
| 02/27/1992 | DE4026382A1 New stable fructose-1,6-bis:phosphate aldolase |
| 02/26/1992 | EP0472286A1 Gene encoding candida albicans plasma membrane H+ATPase |
| 02/26/1992 | EP0472207A2 Hepatitis C assay utilizing recombinant antigens |
| 02/26/1992 | EP0472011A1 Composition containing protease produced by vibrio and method of use in debridement and wound healing |
| 02/26/1992 | EP0471832A1 Improved expression of polypeptides |
| 02/26/1992 | EP0471825A1 PTPase DIAGNOSTICS AND USES THEREOF |
| 02/26/1992 | EP0471687A1 Methods and nucleic acid sequences for the expression of the cellulose synthase operon |
| 02/26/1992 | EP0247145B1 Multiply-amplifiable vectors for high level expression of exogenous dna |
| 02/25/1992 | US5091524 Glycosidase inhibitor salbostatin, process for its preparation, and its use |
| 02/25/1992 | US5091380 N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
| 02/25/1992 | US5091314 Replicating extachromosomal element from escherichia and a multicopy plasmid |
| 02/25/1992 | US5091312 Process for the preparation of sarcosine oxidase |
| 02/25/1992 | US5091305 For specifically hydrolyzing the sulfate ester moiety of bile acid sulfate sulfatase |
| 02/25/1992 | US5091303 Binding of monoclonal antibody to pure p29 protein |
| 02/25/1992 | CA2049482A1 Human cytosolic phospholipase a2 |
| 02/25/1992 | CA1296278C Cell surface modification using a novel glycoproteinase of pasteurella haemolytica |
| 02/25/1992 | CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
| 02/25/1992 | CA1296272C Superoxide dismutase cloning and expression in microorganisms |
| 02/25/1992 | CA1296271C Promoter arrangement for streptomycetes vectors |
| 02/23/1992 | CA2049540A1 Thermostable endoxylanases |
| 02/20/1992 | WO1992002625A1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax |
| 02/20/1992 | WO1992002615A1 Serine protease variants having peptide ligase activity |
| 02/20/1992 | WO1992002613A1 Gram-negative alkaliphilic microorganisms |
| 02/20/1992 | WO1992002612A2 Tissue plasminogen activator variants with decreased clearance |
| 02/20/1992 | WO1992002557A1 arg A HUMAN GENE RELATED TO BUT DISTINCT FROM abl PROTO-ONCOGENE |
| 02/20/1992 | WO1992002553A1 Tumor cell binding molecule with protease inhibiting region |
| 02/20/1992 | WO1992002133A1 Improved diagnostic and therapeutic compositions |
| 02/20/1992 | WO1991019734A3 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 02/19/1992 | EP0471660A2 Protein C for treating pain |
| 02/19/1992 | EP0471651A2 Peptide boronic acid derivatives having protease inhibiting activity |
| 02/19/1992 | EP0471647A2 Restriction-deficient mutants |
| 02/19/1992 | EP0471466A2 DNA sequences which impart resistance to the fungicide 8-chloro-4-(2-chloro-4-fluorophenoxy)quinoline |
| 02/19/1992 | EP0471265A1 Specific protease |
| 02/19/1992 | EP0471259A1 Phenylsulfonamid substituted pyridinealken- and aminooxyalkan-carboxylic-acid derivatives |
| 02/19/1992 | EP0471125A1 Modified protease, method of producing the same and cosmetic compositions containing the modified protease |
| 02/19/1992 | EP0471056A1 Biosynthesis of carotenoids in genetically engineered hosts |
| 02/18/1992 | WO1992003542A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR |
| 02/18/1992 | US5089513 Antiinflammatory agents; antiallergens; asthma; side effect reduction |
| 02/18/1992 | US5089495 Lipoxygenase inhibitors |
| 02/18/1992 | US5089471 Renin inhibitors |
| 02/18/1992 | US5089411 Adding cobalt compound and urea to culture |
| 02/18/1992 | US5089409 Increasing proportion of neutral oligosaccharides in the tissue plasminogen glycoproteins |
| 02/18/1992 | US5089408 Glutathione peroxidase gene and process for production of the gene product |
| 02/18/1992 | US5089402 Exo-type hydrolase capable of hydrolyzing a fructan only every 3 or 4 sugar units |
| 02/18/1992 | US5089401 Reacting a beta-fructofuranoside on a saccharide as a donor in the presence of a receptor selected from xylose, lactose, and galactose |
| 02/18/1992 | US5089398 Enhanced yeast transcription employing hybrid GAPDH promoter region constructs |
| 02/18/1992 | US5089397 Superior mammalian expression system |
| 02/18/1992 | CA2088776A1 Proteases causing abnormal degradation of amyloid .beta.-protein precursor |
| 02/18/1992 | CA2023500A1 Method for isolation and purification of digest from hepatopancreas of crabs |
| 02/18/1992 | CA1296009C ¬(2-imidozol-l-yl ethylthio|-benzoic acid derivative |
| 02/18/1992 | CA1296005C Inhibition of the 5-lipoxygenase pathway |
| 02/18/1992 | CA1295959C Chromosomal dna sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor |
| 02/17/1992 | CA2049188A1 Restriction-deficient mutant |
| 02/14/1992 | WO1992003561A1 HYBRID α-AMYLASE PROMOTERS |
| 02/14/1992 | CA2086824A1 Hybrid.alpha.-amylase promoters |
| 02/14/1992 | CA2048953A1 Borolysine peptidomimetics |
| 02/12/1992 | EP0470832A2 Biphenyl 5,5'-bis-alkanoic acid derivatives, their production and use thereof |
| 02/12/1992 | EP0470575A1 Improved process for producing esterase |
| 02/12/1992 | EP0470331A1 Method for the preparation of fructose-containing oligosaccharide |
| 02/12/1992 | EP0470312A1 Novel omega-carboxyalcohol oxidase |
| 02/12/1992 | EP0470230A1 Method for obtaining and purifying the carboxyl-terminal fragment of the dna polymerase i of streptococcus pneunomiae |
| 02/12/1992 | EP0470192A1 Improved immunoassay including lyophilized reactant mixture. |
| 02/12/1992 | CN1058616A Cloning and overexpression of glucose-6-phosphate dehydrogenase from leuconostoc dextranicus |
| 02/12/1992 | CN1058614A Method for production of superoxide dismutase by use of bacillus |
| 02/12/1992 | CN1015473B Process for biological production of amides |
| 02/11/1992 | US5087614 Inhibits aspartic proteinases |
| 02/11/1992 | US5087572 Anticoagulants |
| 02/11/1992 | US5087569 Antimicrobial proteins, compositions containing same and uses thereof |
| 02/11/1992 | US5087568 Treating solution of copper-free or copper-deficient recombinant human Cu, Zn-superoxide dismutase with copper salt in presence of beta-mercaptoethanol |
| 02/11/1992 | US5087563 Plant carrier protein and Staphylococcus fab fragment; fatty acid sythetase; purification |
| 02/11/1992 | CA1295568C Cloning and utilization of aminotransferase genes |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |
| 02/11/1992 | CA1295566C Characterization and structure of genes for protease a and protease b from streptomyces griseus |
| 02/11/1992 | CA1295565C Enzyme deregulation |
| 02/11/1992 | CA1295563C Production of active proteins containing cystine residues |
| 02/06/1992 | WO1992001814A2 The reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases |
| 02/06/1992 | WO1992001811A1 Assay for ctp-synthetase mutations which cause multidrug resistance |
| 02/06/1992 | WO1992001806A1 Selection of ribozymes that efficiently cleave target rna |
| 02/06/1992 | WO1992001794A2 Ancrod-like proteins, their preparation and their use |
| 02/06/1992 | WO1992001793A1 Cloning and expression of xylanase genes from fungal origin |
| 02/06/1992 | WO1992001782A2 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | CA2067329A1 Cloning and expression of xylanase genes from fungal origin |
| 02/05/1992 | EP0469919A2 A process for the enzymatic preparation of 7-aminocephalosporanic acid |
| 02/05/1992 | EP0469810A1 Plant acetyl-coa carboxylase polypeptide and gene |
| 02/05/1992 | EP0469523A2 Cloning and overexpression of glucose-6-phosphate dehydrogenase of Leuconostoc dextranicus |
| 02/05/1992 | EP0469273A1 Fertile transgenic maize plants with foreign gene as well as method for their production |
| 02/04/1992 | WO1992002637A1 Diagnostic tests for tourette syndrome and related behaviors |
| 02/04/1992 | WO1992002617A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 02/04/1992 | US5086065 Leukotriene antagonists |
| 02/04/1992 | US5086062 Inhibitors of lipoxygenase and-or cyclooxygenase enzymes |
| 02/04/1992 | US5085993 Coenzyme-independent l-sorbosone dehydrogenase from pseudomonas putida |
| 02/04/1992 | CA2067359A1 Diagnostic tests for tourette syndrome and related behaviors |
| 02/04/1992 | CA2048359A1 Dna sequences which impart resistance to the fungicide 8-chloro-4-(2-chloro-4-fluorophenoxy) quinoline |
| 02/03/1992 | WO1992002616A1 Purification of erwinia-l-asparaginase |
| 02/03/1992 | CA2075289A1 Method for the purification of erwinia l-asparaginase |